csirt@kutim:~/threat-intel/cve/CVE-2023-28837

Katalog CVE

CVSS 4.9 · Medium EPSS 1,1%

Kerentanan Uncontrolled Resource Consumption pada torchbox wagtail. Skor CVSS 3.1 4.9 (Medium) menurut NVD.

Deskripsi (NVD)

Wagtail is an open source content management system built on Django. Prior to versions 4.1.4 and 4.2.2, a memory exhaustion bug exists in Wagtail's handling of uploaded images and documents. For both images and documents, files are loaded into memory during upload for additional processing. A user with access to upload images or documents through the Wagtail admin interface could upload a file so large that it results in a crash of denial of service. The vulnerability is not exploitable by an ordinary site visitor without access to the Wagtail admin. It can only be exploited by admin users with permission to upload images or documents. Image uploads are restricted to 10MB by default, however this validation only happens on the frontend and on the backend after the vulnerable code. Patched versions have been released as Wagtail 4.1.4 and Wagtail 4.2.2). Site owners who are unable to upgrade to the new versions are encouraged to add extra protections outside of Wagtail to limit the size of uploaded files.

Rincian

Terbit di NVD
3 April 2023
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
4.9 (Medium), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-400: Uncontrolled Resource Consumption
CWE-770: Allocation of Resources Without Limits or Throttling
EPSS (30 hari)
1,1% peluang dieksploitasi; lebih tinggi dari 63,9% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
torchbox wagtail Semua versi sebelum 4.1.4
torchbox wagtail Versi 4.2 hingga sebelum 4.2.2

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.